Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Other Working Capital Changes (2018 - 2025)

Inmune Bio's Other Working Capital Changes history spans 8 years, with the latest figure at -$55000.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 91.89% year-over-year to -$55000.0; the TTM value through Sep 2025 reached $533000.0, up 178.38%, while the annual FY2024 figure was -$52000.0, 1200.0% down from the prior year.
  • Other Working Capital Changes for Q3 2025 was -$55000.0 at Inmune Bio, down from $2000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.9 million in Q2 2022 and bottomed at -$2.3 million in Q4 2022.
  • The 5-year median for Other Working Capital Changes is $1000.0 (2024), against an average of $105.26.
  • The largest annual shift saw Other Working Capital Changes skyrocketed 1953.4% in 2022 before it crashed 67700.0% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$981000.0 in 2021, then tumbled by 134.56% to -$2.3 million in 2022, then soared by 98.52% to -$34000.0 in 2023, then soared by 1847.06% to $594000.0 in 2024, then crashed by 109.26% to -$55000.0 in 2025.
  • Per Business Quant, the three most recent readings for INMB's Other Working Capital Changes are -$55000.0 (Q3 2025), $2000.0 (Q2 2025), and -$8000.0 (Q1 2025).